공시 • Aug 25
CVS Pharmacy, Inc. completed the acquisition of Pharmacy Assets from Rite Aid Corporation. CVS Pharmacy, Inc. entered into sale agreement to acquire Pharmacy Assets from Rite Aid Corporation on May 15, 2025. The sale transactions are subject to approval by the U.S. Bankruptcy Court for the District of New Jersey (the “Court”). The Court is currently scheduled to conduct a hearing to approve the sales on May 21, 2025. Upon approval from the Court, the sales will remain subject to certain regulatory notices and approvals, and other customary closing conditions.
Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor for Rite Aid Corporation. Guggenheim Securities, LLC acted as financial advisor for Rite Aid Corporation. Alvarez & Marsal Holdings, LLC acted as financial advisor for Rite Aid Corporation. Joele Frank, Wilkinson Brimmer Katcher is serving as strategic communications advisor to Rite Aid Corporation.
CVS Pharmacy, Inc. completed the acquisition of Pharmacy Assets from Rite Aid Corporation on October 15, 2025. 공시 • Sep 05
Rite Aid Corporation COM PAR Deleted from OTC Equity Rite Aid Corporation COM PAR $1.00 has been deleted from OTC Equity effective September 03, 2024, due to Bankruptcy Plan Effective/Shares Cancelled. 공시 • Sep 04
Rite Aid Corporation Announces Resignation of Jeffrey S. Stein, as Chief Restructuring Officer Rite Aid Corporation announced Jeffrey S. Stein, who has stepped down as Chief Restructuring Officer in connection with the Company’s emergence from Chapter 11. 공시 • Apr 05
Rite Aid Announces Availability of Opill At All Locations Rite Aid Corporation announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores. Opill is a progestin-only, daily oral contraceptive (birth control pill) that’s safe and effective when used as directed to help prevent pregnancy. Opill over-the-counter birth control pills are available at Rite Aid for the suggested retail price of $19.99 for a one-month supply and $49.99 for a three-month supply. Both options are available for purchase at Rite Aid stores nationwide and online at RiteAid.com. There are no restrictions for purchasing Opill. Rite Aid pharmacists are available to answer any customer questions about Opill. 공시 • Jan 31
Rite Aid Corporation (OTCPK:RADC.Q) acquired Tuttles Pharmacy Inc from Pellegrini family. Rite Aid Corporation (OTCPK:RADC.Q) acquired Tuttles Pharmacy Inc. from Pellegrini family on January 29, 2024.Rite Aid Corporation (OTCPK:RADC.Q) completed the acquisition of Tuttles Pharmacy Inc. from Pellegrini family on January 29, 2024. 공시 • Jan 13
Rite Aid Corporation announced delayed 10-Q filing On 01/12/2024, Rite Aid Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Nov 21
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Rite Aid Corporation Securities Litigation The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Rite Aid Securities Litigation: Investor purchased or acquired Rite Aid Corporation (Rite Aid) common stock between October 20, 2016 and June 28, 2017, inclusive (the “class”), investor could receive a payment from a class action settlement. Certain persons are excluded from the definition of the class as set forth in the stipulation of settlement. Pursuant to Rule 23 of the Federal Rules of Civil Procedure and by Order of the United States District Court for the Middle District of Pennsylvania, that in the above-captioned litigation (the “Action”), which is a certified class action, a Settlement has been proposed for $192,500,000.00 in cash. A hearing will be held on February 7, 2024, at 1:30 p.m., before the Honorable Jennifer P. Wilson, in Courtroom 8A, at the United States District Court for the Middle District of Pennsylvania, Sylvia H. Rambo U.S. Courthouse, 1501 North 6th Street, Harrisburg, PA 17102, for the purpose of determining whether: (1) the proposed Settlement should be approved by the Court as fair, reasonable, and adequate; (2) the proposed Plan of Allocation for distribution of the Settlement proceeds is fair, reasonable, and adequate and therefore should be approved; and (3) the application of Lead Counsel for the payment of attorneys’ fees and expenses from the Settlement Fund, including interest earned thereon, and requests by Plaintiffs for their time and expenses, should be approved. 공시 • Oct 21
Rite Aid Corporation Announces Board Appointments On October 15, 2023, Rite Aid Corporation appointed Carrie Teffner and Paul Keglevic to the Company’s Board of Directors. Upon appointment, Mr. Keglevic and Ms. Teffner joined the Audit Committee of the Board, where Mr. Keglevic will serve as Chair. Ms. Teffner was also appointed as a member of the Compensation Committee of the Board. In connection with their respective appointments, Ms. Teffner and Mr. Keglevic will each be entitled to receive a cash directors’ fee equal to $50,000 per month, payable in arrears, and reimbursement for travel and lodging expenses associated with the directors’ services on the Board. Ms. Teffner has over 30 years of strategic, financial and operational leadership experience assisting retail and consumer product companies in driving growth and profitability. She has deep expertise leading successful large-scale transformation initiatives and has served as Executive Vice President and Chief Financial Officer at several Fortune 500 companies. Ms. Teffner currently serves on the boards of DXC Technology, International Data Group and BFA Industries. She previously served on the boards of Ascena Retail Group, Avaya and GameStop. Mr. Keglevic is an NACD-certified director with over 45 years of leadership experience and deep expertise in finance and accounting, operational improvement and turnarounds, restructuring and risk management across a range of industries. He has served as CEO, CFO, Chief Restructuring Officer and Chief Risk Officer at numerous companies, most recently as CEO of Energy Future Holdings. Earlier in his career, Mr. Keglevic was a Partner and member of the U.S. leadership team at PricewaterhouseCoopers. He currently serves on the boards of WeWork, Evergy and Envision Healthcare. Mr. Keglevic previously served on the boards of Ascena Retail Group, Bonanza Creek Energy, Clear Channel Holdings, Cobalt International Energy and Frontier Communications, among others. Prior to their respective appointments, Ms. Teffner and Mr. Keglevic, each entered into a letter agreement with the Company, dated as of July 5, 2023, pursuant to which Ms. Teffner and Mr. Keglevic provided consulting services to the Company on matters relating to refinancing, restructuring and deleveraging for the period between July 5, 2023 until their respective appointments on October 15, 2023. During such time, Ms. Teffner and Mr. Keglevic each received $200,000 in the aggregate, consisting of monthly fees payable by the Company pursuant to their respective letter agreements. 공시 • Oct 20
Rite Aid Corporation(OTCPK:RADC.Q) dropped from S&P TMI Index Rite Aid Corporation(OTCPK:RADC.Q) dropped from S&P TMI Index 공시 • Oct 17
Rite Aid Corporation Filed for Bankruptcy Rite Aid Corporation, along with its 121 affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of New Jersey on October 15, 2023. The debtor listed both its assets and liabilities in the range of $1 billion to $10 billion. The debtor is represented by Michael D. Sirota of Cole Schotz P.C., Kirkland & Ellis LLP and Kirkland & Ellis International LLP as its legal counsels. The debtor also hired Guggenheim Partners as its investment banker, Alvarez & Marsal North America, LLC as its financial, tax, and restructuring advisor and Kroll Restructuring Administration as its notice and claims agent. 공시 • Oct 13
Rite Aid Corporation announced delayed 10-Q filing On 10/12/2023, Rite Aid Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Sep 26
Rite Aid Corporation is Heading Towards Bankruptcy Rite Aid Corporation is heading towards bankruptcy, as of September 22, 2023. Company is expected to file a Chapter 11 bankruptcy petition within the next couple of days as it nears an agreement with existing creditors. The company is finalizing a reorganization pact with its largest creditors/ is leading towards a bankruptcy proceeding under Chapter 11. 공시 • Sep 16
Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine Rite Aid announced that scheduling is now available for eligible customers seeking the updated COVID-19 (2023-2024) vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. Appointments are available beginning on September 22. The updated COVID-19 vaccine provides enhanced protection against currently circulating variants of COVID-19. The vaccine is recommended for individuals six months and older. An updated COVID-19 vaccine is needed for those who have not received a COVID-19 vaccine in the past two months, according to the CDC. Rite Aid pharmacists are trained to immunize customers ages three and older. Other immunizations, including the flu vaccine, can also be scheduled via the online scheduling tool. Both the COVID-19 and flu vaccinations can be administered during the same appointment. 공시 • Sep 12
Rite Aid Announces Availability of OTC NARCAN Nasal Spray At All Locations Rite Aid announced that NARCAN Nasal Spray, a medication used to reverse the effects of an opioid overdose, is available at all locations nationwide, including Bartell Drugs in the Pacific Northwest. NARCAN Nasal Spray can be purchased over the counter without a prescription. NARCAN Nasal spray (naloxone HCl 4 mg) is a medication designed to rapidly reverse the effects of a life-threatening opioid emergency and is the standard treatment for opioid overdose. It is now FDA-approved for OTC use and is available for purchase at Rite Aid stores nationwide and online at Rite Aid.com. Each carton of NARCAN Nasal Spray contains two single-dose devices. Each device contains one dose of medicine. The carton is readily available on shelves and at the pharmacy counter at Rite Aid stores and is priced at $45.99. 공시 • Aug 05
Rite Aid Corporation Announces Availability of Flu and RSV Vaccine Appointments at All Locations Rite Aid Corporation announced appointments for flu and RSV vaccines are available at all store locations, including Bartell Drugs in the Pacific Northwest. Customers can now schedule appointments to protect themselves and family members against the upcoming respiratory virus season through Rite Aid's online scheduler. Rite Aid will be offering flu vaccines protecting against the strains of influenza that are expected to circulate in the United States this year, as well as Flumist, a nasal spray flu vaccine, which is in limited supply at all locations. Customers receiving their flu shot will get a coupon for $5 off a $25 in-store purchase from now until Sept. 30, 2023. This offer excludes stores in New York or New Jersey and some restrictions apply. The Centers for Disease Control (CDC) recommends adults 60 years and older receive a single dose of RSV vaccine, based on discussions with their pharmacist or other healthcare provider. The RSV vaccine may be given at the same time as other vaccines. Rite Aid and Bartell Drugs also offer COVID-19 and other routine vaccinations at all locations, helping customers and families stay up to date on vaccines that provide critical protection against certain diseases, some of which are required for certain ages, activities or for overseas travel. Rite Aid and Bartell drugs will provide the new CDC-recommended COVID-19 vaccine once available, which will better protect against the most prevalent COVID-19 strain. Rite Aid pharmacists can provide additional guidance on which vaccines are right for each customer and advise on the timing of administration of each vaccine. To help customers assess their needs for routine immunizations, Rite Aid offers an Immunization Evaluation Questionnaire on its website. The questionnaire guides customers to ensure they are up to date with all necessary immunizations based on their age, conditions, or occupation. Rite Aid and Bartell's pharmacists can immunize adults and children three years of age and older against influenza. To schedule an appointment for a flu vaccine or other immunizations, Rite Aid customers can use the online scheduling tool at Rite Aid.com. Bartell Drugs customers can use the online scheduling tools linked here. All locations are currently accepting walk-ins. How online scheduling works: Using the online scheduling tool, customers may select a convenient time and location to schedule a vaccine appointment for flu, COVID-19 and other recommended vaccinations. Customers supply necessary information and consent forms securely online in advance of their appointment. Reminders will be sent in the days leading up to the appointment via customers' chosen communication preferences by text or email. 공시 • Aug 02
Rite Aid Corporation Announces Executive Changes Rite Aid Corporation announced that on July 28, 2023, Justin Mennen, the EVP and Chief Digital and Technology Officer of the Company, ceased to be employed by the Company, effective immediately. Board Change • Jul 26
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Director Bari Harlam was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공시 • Jun 30
Rite Aid Corporation, Annual General Meeting, Aug 18, 2023 Rite Aid Corporation, Annual General Meeting, Aug 18, 2023, at 11:30 US Eastern Standard Time. Agenda: To consider the Election of six directors to hold office until the 2024 Annual Meeting of Stockholders the Board's nominees; to consider Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm; to consider Advisory vote to approve the compensation of our named executive officers; to consider Advisory vote on the frequency of future advisory votes to approve the compensation of our named executive officers; to consider Approval of the amendments to the Rite Aid Corporation Amended and Restated Certificate of Incorporation to eliminate supermajority voting provisions; to Consider and vote on a stockholder proposal to require an annual advisory vote on the compensation of Rite Aid's directors, if properly presented at the Annual Meeting; and to consider other business matters. 